Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001439222-24-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-29 | 2024-02-27 | AGIO | Schenkein David P | Dir | S - Sale+OE | $34.67 | -69.3K | 122.9K | -36% | -$2.40M |
| DM | 2024-02-29 | 2024-02-27 | AGIO | Schenkein David P | Dir | M - OptEx | $31.64 | +69.3K | 180.3K | +62% | +$2.19M |
| DM | 2024-02-29 | 2024-02-27 | AGIO | Schenkein David P | Dir | M - OptEx | $0.00 | -69.3K | 57.5K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-02-27 | S | D | 11,858 | $33.60 | 122,854 | D | — | — | (F1) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $33.02 to $34.41. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common stock | 2024-02-27 | S | D | 57,471 | $34.89 | 122,854 | D | — | — | (F2) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $34.64 to $35.28. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common stock | 2024-02-27 | M | A | 11,858 | $31.64 | 134,712 | D | — | — | |
| 4 | Common | Common stock | 2024-02-27 | M | A | 57,471 | $31.64 | 180,325 | D | — | — | |
| 5 | Derivative | Stock option (right to buy) | 2024-02-27 | M | D | 57,471 | $0.00 | 0 | D | $31.64 · — to 2024-03-04 | 57,471 Common stock | (F5) This option was originally granted on March 5, 2014 for the purchase of 148,770 shares of common stock. The shares underlying this option vested as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. |
| 6 | Derivative | Stock option (right to buy) | 2024-02-27 | M | D | 11,858 | $0.00 | 57,471 | D | $31.64 · — to 2024-03-04 | 11,858 Common stock | (F5) This option was originally granted on March 5, 2014 for the purchase of 148,770 shares of common stock. The shares underlying this option vested as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. |